Nobel Laureate Randy Schekman Appointed Honorary Scientist for EZZ Life Sciences
Recently, EZZ Life Sciences, a listed company on the Main Board of the Australian Stock Exchange and a leading genome company in Australia, announced in the United States the news of the appointment of the group’s new honorary scientist: Randy W. Schekman, the winner of the 2013 Nobel Prize in Physiology or Medicine.
According to industry insiders, as one of the world’s most outstanding cell medicine scientists, Randy Schekman’s profound attainments in cell medicine coincide with EZZ Life Science’s pursuit of using cell and gene technology to solve human health problems. The joining of Randy Schekman could elevate EZZ’s research and development capabilities to a new level, allowing global consumers to share the most cutting-edge gene technology industrialization achievements.
The reporter learned that, a few days ago, EZZ Life Science R&D Director, on behalf of the company, signed an employment agreement with Randy W. Schekman in the United States, and formally appointed him as an honorary scientist of EZZ Life Science. Randy W. Schekman is known as the greatest cytologist in the world. He is a molecular and cell biology professor at the University of California, Berkeley, a member of the National Academy of Sciences, and his most famous identity is a Nobel Prize winner.
It is reported that Randy Schekman’s research mainly involves the fields of cell biology, molecular biology, and gene research. He won the 2013 Nobel Prize in Physiology or Medicine for his research on the gene regulation mechanism of protein transport.
As a life science company that has rapidly “become widely known” in the world in recent years, EZZ Life Science Holdings Limited, which Randy Schekman chose to work for, is a company listed on the main board of the ASX. The company is committed to the prospect of human health and longevity Research, focusing on researching and developing genetic technologies to address four critical human health challenges: genetic longevity, human papillomavirus (HPV), Helicobacter pylori, and weight management.
At the inauguration ceremony that day, Randy W. Schekman said: “EZZ Life Science has the industry’s first-class scientific research level. It has always been at the forefront of the latest developments in anti-aging, adolescent growth and development, female beauty, and basic health. Their dedication to scientific research and producing high-quality, innovative products have made them industry pioneers, which coincides with my values. “He said, “As a Nobel laureate in Physiology or Medicine, I am thrilled to be a member of the EZZ Life Science team and look forward to our joint efforts to make scientific research truly benefit consumers worldwide.”
Media Contact
Company Name: American Star News
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: www.deiniolnews.com
